Calidi Biotherapeutics Inc. (CLDI) — Financial Flexibility Index
Calidi Biotherapeutics Inc. (CLDI) has a Financial Flexibility Index of -0.98x as of December 2025. Free cash flow of $-5.01 Million (operating CF $-5.04 Million minus capex $29.00K) represents -1% of total liabilities ($5.10 Million). Check CLDI intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Calidi Biotherapeutics Inc. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Calidi Biotherapeutics Inc. across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Calidi Biotherapeutics Inc. generate cash.
Annual Financial Flexibility Index for Calidi Biotherapeutics Inc. (2020–2025)
Year-by-year free cash flow to debt coverage for Calidi Biotherapeutics Inc.. Explore CLDI debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.15x | $-21.17 Million | $-21.29 Million | $5.10 Million | ▼ -157.8% |
| 2024 | -1.61x | $-19.68 Million | $-19.69 Million | $12.21 Million | ▼ -11.4% |
| 2023 | -1.45x | $-26.40 Million | $-26.98 Million | $18.25 Million | ▼ -499.9% |
| 2022 | -0.24x | $-12.79 Million | $-13.21 Million | $53.04 Million | ▲ +17.2% |
| 2021 | -0.29x | $-7.57 Million | $-7.77 Million | $26.00 Million | ▼ -58.3% |
| 2020 | -0.18x | $-4.47 Million | $-4.83 Million | $24.33 Million | — |